Publicaciones en las que colabora con Manuel Barreiro de Acosta (22)

2024

  1. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on sexuality and inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 774-792

2023

  1. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Rapidity of clinical response to adalimumab and improvement of quality of life in luminal Crohn's disease: RAPIDA study

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 3, pp. 165-176

2021

  1. Recommendations of the Spanish Working Group on Crohn's disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa — GETECCU) on dysplasia screening in inflammatory bowel disease patients

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 6, pp. 435-447

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

    Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854

2015

  1. Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: Predictors of efficacy in clinical practice

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 4, pp. 430-435

  2. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: A cross-sectional study

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 9, pp. 1030-1037

2014

  1. Drug trough levels and primary nonresponse to antiTNF therapy in moderate-severe Crohn disease

    Gastroenterology, Vol. 146, Núm. Suppl. 1, pp. 247

  2. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry

    Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769

2013

  1. Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): The SPIRIT registry

    Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 73-80

  2. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients

    Pharmacogenomics, Vol. 14, Núm. 6, pp. 631-640

2012

  1. Tu1909 An Exome-Wide Genotyping Analysis for the Identification of Candidate Genes Associated With the Response to the Thiopurine Therapy in Inflammatory Bowel Disease Patients

    Gastroenterology, Vol. 142, Núm. 5, pp. S-875

2011

  1. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving azathioprine

    Journal of Gastrointestinal and Liver Diseases, Vol. 20, Núm. 3, pp. 247-253

  2. New Genetic Associations Detected in an Exome-Wide Association Study for Toxicity Related to Thiopurine Treatments in Inflammatory Bowel Disease

    Gastroenterology, Vol. 140, Núm. 5, pp. S-271

  3. Pharmacogenetics study of TPMT and ITPA genes in patients with inflammatory bowel disease treated with azathioprine detects relation between ITPase deficiency and clinical response

    Journal of Crohns & Colitis, Vol. 5, Núm. 1, pp. S162-S161

2010

  1. Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events

    Journal of Crohn's and Colitis, Vol. 4, Núm. 3, pp. 301-311

  2. Ulcerative colitis in northern Portugal and Galicia in Spain

    Inflammatory Bowel Diseases, Vol. 16, Núm. 7, pp. 1227-1238

2009

  1. M1130 Influence of Environmental Factors in the Severity of Inflammatory Bowel Disease

    Gastroenterology, Vol. 136, Núm. 5, pp. A-356